Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Assets: 2009-2024

Historic Assets for Cumberland Pharmaceuticals (CPIX) over the last 16 years, with Dec 2024 value amounting to $75.6 million.

  • Cumberland Pharmaceuticals' Assets fell 14.14% to $65.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $65.9 million, marking a year-over-year decrease of 14.14%. This contributed to the annual value of $75.6 million for FY2024, which is 7.57% down from last year.
  • As of FY2024, Cumberland Pharmaceuticals' Assets stood at $75.6 million, which was down 7.57% from $81.8 million recorded in FY2023.
  • Cumberland Pharmaceuticals' Assets' 5-year high stood at $96.5 million during FY2020, with a 5-year trough of $75.6 million in FY2024.
  • Moreover, its 3-year median value for Assets was $81.8 million (2023), whereas its average is $83.4 million.
  • As far as peak fluctuations go, Cumberland Pharmaceuticals' Assets fell by 12.44% in 2021, and later rose by 10.02% in 2022.
  • Cumberland Pharmaceuticals' Assets (Yearly) stood at $96.5 million in 2020, then dropped by 12.44% to $84.5 million in 2021, then climbed by 10.02% to $92.9 million in 2022, then declined by 12.00% to $81.8 million in 2023, then decreased by 7.57% to $75.6 million in 2024.